NewsDialy
A growing number of congressional lawmakers are urging the Trump administration to reconsider a federal rule set to take effect next month.
Critics warn the regulation will prevent Americans from obtaining prescription medicines from licensed international pharmacies.
The pending rule mandates that medicines mailed from abroad pass through a specific customs process requiring a licensed customs broker and a financial guarantee known as an entry bond.
These new requirements add both burden and cost for individuals who have historically received prescriptions from Canada and other countries to save money on expensive drugs.
Keep reading